Avena fatua L. populations from numerous fields in Alberta have simultaneously developed resistance to recommended rates of two dissimilar herbicides, triallate and difenzoquat. We used exogenous applications of gibberellic acid (GA3) to investigate the possibility that endogenous gibberellins were involved in the A. fatua's resistance mechanism. For control plants, without applied GA3, shoots of the most resistant (R) populations emerged more rapidly and elongated faster than shoots of the susceptible (S) populations. Increases in shoot elongation in response to exogenous GA3 were significantly lower in R populations compared with S populations. This suggests that R populations may have elevated endogenous gibberellin levels, relative to S populations. Additionally, inhibition of S population shoot elongation and shoot anatomical abnormalities caused by relatively low concentrations of triallate and difenzoquat could be prevented by exogenous application of GA3. These results suggest that there may be a phytohormonal involvement in the mechanism of triallate/difenzoquat resistance in A. fatua. That is, higher endogenous gibberellin levels in R populations may result in meristematic growth that is rapid enough to preclude phytotoxic levels of these herbicides from reaching the shoot meristem, which is the likely site of action.
No takes yet. Share an insight, caveat, or question.
Rashid et al. (1998) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: